Added to YB: 2026-07-06
Pitch date: 2026-07-01
IRIX [bullish]
IRIDEX Corporation
-1.74%
current return
Author Info
Trident Opportunities writes about deep value and special situation investment opportunities. Sign up for the newsletter.
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$19.7M
Pitch Price
$1.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
-18.45
P/E
-5.89
EV/Sales
0.48
Sector
Health Care Equipment and Supplies
Category
turnaround
Trident Opportunities | Portfolioupdate Q2 - 2026 - +31,2% YTD - IRIDEX Corporation
IRIX (added to position): Medtech at <0.5x EV/Rev with genuine path to profitability this year. Q1 beat on revenue, GPM & adj EBITDA. FY guide $51-53M rev, 37-43% GPM, $19-19.5M opex (ex-D&A/SBC). Tailwinds: favorable reimbursement, strong clinical data, margin initiatives (contract mfg). Q4 profitability likely well above run-rate. Portfolio +31.2% YTD.
Read full article (2 min)